These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15630040)

  • 21. Secondary prevention in concurrent coronary artery, cerebrovascular, and chronic kidney disease: focus on pharmacological therapy.
    Notaro LA; Usman MH; Burke JF; Siddiqui A; Superdock KR; Ezekowitz MD
    Cardiovasc Ther; 2009; 27(3):199-215. PubMed ID: 19689620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arterial hypertension - the specific case].
    Weisser B; Düsing R; Mengden T
    Dtsch Med Wochenschr; 2001 Nov; 126(44):1235. PubMed ID: 11687982
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current therapeutics 2000].
    Scheen AJ
    Rev Med Liege; 2000 Sep; 55(9):852-61. PubMed ID: 11105601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
    Mertz DP; Sulzberger I; Klöpfer M
    Munch Med Wochenschr; 1970 Feb; 112(6):241-7. PubMed ID: 5537894
    [No Abstract]   [Full Text] [Related]  

  • 25. [Editorial: hypertensiology].
    Hitzenberger G
    Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
    [No Abstract]   [Full Text] [Related]  

  • 26. ALLHAT: a saga of missed opportunities.
    McInnes GT
    J Hum Hypertens; 2003 Jun; 17(6):373-7. PubMed ID: 12764398
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug prevention of coronary disease].
    Miettinen TA
    Duodecim; 1972; 88(21):1346-54. PubMed ID: 4570871
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypertensive complications--a common geriatric problem.
    Franciosa JA; Simon G; Eckhoff PA
    Geriatrics; 1980 Oct; 35(10):65-9, 72-3. PubMed ID: 7439691
    [No Abstract]   [Full Text] [Related]  

  • 29. The hidden effects of antihypertensive and lipid-lowering agents on the prevention and regression of atherogenesis: new management strategies.
    Weinberg MS
    R I Med; 1995 Mar; 78(3):78-81. PubMed ID: 7734758
    [No Abstract]   [Full Text] [Related]  

  • 30. Is age associated with the number or types of medications prescribed to renal transplant recipients?
    Chisholm MA; Melroy J; Johnson M; Mulloy LL; Spivey CA
    J Am Geriatr Soc; 2007 Mar; 55(3):389-94. PubMed ID: 17341241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Poor control of risk factors prior to heart surgery. High proportion of undiscovered diabetes, undertreated hypertension and hyperlipidemia].
    Anderson RE; Brismar K; Lindberg A; Hylander S; Alserius T; Ivert T
    Lakartidningen; 2007 Mar 21-27; 104(12):936-40. PubMed ID: 17469307
    [No Abstract]   [Full Text] [Related]  

  • 32. American Diabetes Association--66th scientific sessions. Updates on drug treatments. 9-13 June 2006, Washington, DC, USA.
    Jago C
    IDrugs; 2006 Aug; 9(8):542-4. PubMed ID: 16871460
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of pharmacologic agents for treatment of diabetes mellitus, dyslipidemia, and hypertension in children and adolescents.
    Daniels SR
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):389-91. PubMed ID: 19349572
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection.
    Gedela K; Vibhuti M; Pozniak A; Ward B; Boffito M
    HIV Med; 2014 May; 15(5):257-68. PubMed ID: 24351025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of argyria after colloidal silver ingestion.
    Chang AL; Khosravi V; Egbert B
    J Cutan Pathol; 2006 Dec; 33(12):809-11. PubMed ID: 17177941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of serum creatine kinase elevation and its relation to medications used after heart transplantation.
    Hsu RB; Chen RJ; Wang SS; Chu SH
    Clin Transplant; 2005 Feb; 19(1):45-50. PubMed ID: 15659133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular and renal benefits are additive using intensive blood pressure control and incremental glucose control in type 2 diabetic patients.
    Cardiovasc J Afr; 2008; 19(5):284-6. PubMed ID: 18997995
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic management].
    Vanzetto G; Fouque D; Moulin B; Halimi S; Kessler M; Bayle F
    Nephrologie; 2000; 21(7):383-92. PubMed ID: 11200619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.